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BACKGROUND
Chagas disease is endemic to South and Central America
and frequently affects patients in their most productive
working years. As a result, the disease is very costly for
governments and societies.
1 Chronic cardiomyopathy is the
most severe manifestation of human Chagas disease and
can cause chronic heart failure (CHF), arrhythmia, heart
block and sudden death.
2
Exercise capacity has been shown to be related to poor
survival in patients with Chagas disease. Previous studies
have demonstrated that patients with Chagas infection
present a poorer prognosis compared to patients with other
causes of CHF.
3 Despite these findings, data describing
exercise training in CHF patients with Chagas disease are
rare, especially regarding the use of the new and promising
exercise training method known as neuromuscular electro-
stimulation (NMEE).
Case report
A 65-year-old sedentary male patient with 10 years of
CHF symptoms due to Chagas disease was referred to the
Department of Cardiac Rehabilitation of the Ana Neri
Hospital - UFBA in August of 2009. The diagnosis of Chagas
disease was defined by the positive result of two serological
tests [indirect immunofluorescence and enzyme-linked
immunosorbent assay (ELISA)]. To exclude the possibility
of an ischemic heart disease, the patient underwent cardiac
catheterization, followed by angiography. The studied
patient was in New York Heart Association (NYHA)
functional class IV and had a left ventricular ejection
fraction of 40%. An evaluation of patient exercise capacity
by a cardiopulmonary exercise test was initially attempted;
however, the patient could not tolerate the testing because
of excessive fatigue in the first minute of the exam. Instead,
a six-minute walking test in a 30-m corridor was performed
to evaluate the patient’s exercise capacity. For this test,
previously standardized instructions were followed.
4 In
addition, the Minnesota Living With Heart Failure
Questionnaire was administered (Table 1).
5
After the initial assessment, the physiotherapy team chose
the NMEE protocol for rehabilitation because of the
patient’s significant functional impairment and his inability
to undergo conventional exercise training (Table 1).
6 NMEE
was performed on the right and left quadriceps for 60
minutes three times a week during for four weeks. NMEE
was applied via an electrostimulator (Phisiotonus II, Bioset)
on functional electrical stimulation (FES) mode. The carrier
wave frequency was modulated at 50 Hz, with a pulse
duration of 40 ms. The stimulator was set to deliver 20
seconds of contraction and 4 seconds of relaxation.
Adhesive surface electrodes 3 cm in diameter were used
for electrostimulation. The current intensity was adjusted
according to the sensitivity threshold of the patient.
The patient’s current medication (carvedilol 12.5 mg/day,
captopril 75 mg/day and furosemide 40 mg/day) was not
changed during the protocol. This protocol was approved
by the Ethical Committee of our institution, and the patient
provided informed consent prior to participation.
DISCUSSION
The NMEE protocol was well tolerated by the patient, and
no adverse events occurred.
7 After the protocol, the patient
performed another six-minute walking test and answered
the Minnesota Living With Heart Failure Questionnaire.
This reevaluation indicated a 380-meter increase in walked
distance and a decrease of 15 points on the quality of life
questionnaire score (Table 1).
In patients with Chagas disease, exercise training is an
important aspect of cardiovascular rehabilitation; however,
there are a minimum of controlled trials regarding this
subject in the literature. The lack of trials may be related to
the small prevalence of Chagas disease in developed
countries or the high Chagas disease-associated incidence
of malignant arrhythmia, sudden death and a consequent
poor prognosis.
2,3
Despite a recent upsurge in the interest regarding the use
of NMEE for treatment of CHF patients, there are only a
modest number of small trials. Moreover, these trials do not
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927examine the etiology of Chagas disease. In CHF populations
with left ventricular systolic dysfunction, NMEE appears to
produce the same benefits as conventional physical exercise
training by increasing both exercise capacity and quality of
life.
8,9 NMEE appears to be particularly useful in patients
unable to perform conventional exercises, such as those in
NYHA functional class IV.
10
In the current report, the studied patient demonstrated
severe functional impairment prior to treatment, which may
have contributed to the large functional improvement
observed in the relatively short intervention time. The
functional capacity of patients in the initial phase of chronic
Chagas heart disease is higher than those in advanced
phases.
11
CONCLUSION
In the present report, NMEE was demonstrated to be a
safe and efficient tool for improving exercise capacity
during cardiac rehabilitation in a CHF patient with
Chagas disease. Further studies are necessary to better
elucidate the risks, benefits and indications of NMEE.
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Table 1 – Patient data before and after NMEE treatment.
Before After
NYHA functional class IV III
Body Mass Index (kg/m
2) 19.1 19.4
Resting SBP (mmHg) 100 110
Resting DBP (mmHg) 80 80
Resting HR (bpm) 54 57
SBP during 6WT (mmHg) 110 130
DBP during 6WT (mmHg) 80 80
HR during 6WT (bpm) 75 68
Distance 6WT (meters) 120 500
MLHFQ Score 65 50
Borg Scale during 6WT 19 13
SpO2 during 6WT (%) 95 97
NYHA, New York Heart Association Functional Class; SBP, Systolic blood
pressure; DBP, Diastolic blood pressure; HR, heart rate; MLHFQ, Minnesota
Living with Heart Failure Questionnaire; 6WT, 6-minute walking test.
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